Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis.
Leuk Res
; 60: 31-35, 2017 09.
Article
in En
| MEDLINE
| ID: mdl-28646676
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Danazol
/
Drug Therapy, Combination
/
Primary Myelofibrosis
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leuk Res
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom